Sanjay Bhanot

14.9k citations

109 papers · 11.1k indexed · 4 hit papers · h-index 50

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diet, Metabolism, and Disease
Biochemistry top 0.2%
- Lipid metabolism and biosynthesis

Papers in

Biochemistry 15
- Lipid metabolism and biosynthesis 11
Endocrinology, Diabetes and Metabolism 33
- Diet, Metabolism, and Disease 19

Co-authors: Brett P. Monia Robert A. McKay John H. McNeill Gerald I. Shulman Varman T. Samuel Xing Yu Sanjay K. Pandey Lynnetta M. Watts
Journals: Diabetes (10 papers)Nucleic Acid Therapeutics (6 papers)Journal of Clinical Investigation (5 papers)Journal of Biological Chemistry (5 papers)Hepatology (5 papers)
Partner nations: United States Canada Germany

In The Last Decade

Sanjay Bhanot

108 papers receiving 10.9k citations

Hit Papers

align trajectories log scale

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis 2014 · 455 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 New England Journal of Medicine
2014 Nature
2007 Hepatology
2006 Cell Metabolism

Peers

Countries citing papers authored by Sanjay Bhanot

Since Specialization

Citations

This map shows the geographic impact of Sanjay Bhanot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Bhanot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Bhanot more than expected).

Fields of papers citing papers by Sanjay Bhanot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Bhanot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Bhanot. The network helps show where Sanjay Bhanot may publish in the future.

Co-authors

The 25 scholars most cited alongside Sanjay Bhanot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sanjay Bhanot Line = papers co-authored together Sanjay Bhanot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and Tolerability of GalNAc ₃ -Conjugated Antisense Drugs Compared to the Same-Sequence 2′- O -Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data Nucleic Acid Therapeutics ·Brenda F. Baker, Shuting Xia, Овсянников Михаил Сергкквич, Jeffery A. Engelhardt, Sotirios Tsimikas, Stanley T. Crooke, Sanjay Bhanot, Richard S. Geary	2024	4
2	Integrated Assessment of Phase 2 Data on GalNAc ₃ -Conjugated 2′- O -Methoxyethyl-Modified Antisense Oligonucleotides Nucleic Acid Therapeutics ·Brenda F. Baker, Shuting Xia, Овсянников Михаил Сергкквич, T. Jesse Kwoh, Sotirios Tsimikas, Sanjay Bhanot, Richard S. Geary	2022	11
3	PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients CPT Pharmacometrics & Systems Pharmacology ·Stefan Willmann, Kuldeep Srivastav, بوبكر موسى, Alexander Solms, Markus Jensen, Maximilian T. Lobmeyer, Anthonie W.A. Lensing, Claudette Bethune, Erin Morgan, Rosie Z. Yu, Yanfeng Wang, Shiangtung W. Jung, Richard S. Geary, Sanjay Bhanot	2021	36
4	Improvements in the Tolerability Profile of 2′- O -Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods Nucleic Acid Therapeutics ·Овсянников Михаил Сергкквич, Shuting Xia, T. Jesse Kwoh, Sanjay Bhanot, Richard S. Geary, Brenda F. Baker	2021	8
5	Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy Diabetes Care ·Erin Morgan, Bruce L. Tai, Nguyen C. Pham, Antho Thohirin, Lynnetta M. Watts, 一夫重森, Shiangtung W. Jung, Martin Gajdošík, Martin Krššák, Michael Krebs, Richard S. Geary, Brenda F. Baker, Sanjay Bhanot	2019	42
6	The Effects of 2′- O -Methoxyethyl Oligonucleotides on Renal Function in Humans Nucleic Acid Therapeutics ·Stanley T. Crooke, Brenda F. Baker, Nguyen C. Pham, Steven G. Hughes, T. Jesse Kwoh, Nicolas Pillaud, Sotirios Tsimikas, Richard S. Geary, Sanjay Bhanot	2017	53
7	Pharmacokinetics and Pharmacodynamics of Ionis-FXIRx, an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis Blood ·Claudette Bethune, Michael Walsh, Li Peng Zhao, Rosie Z. Yu, Richard S. Geary, Sanjay Bhanot	2017	18
8	The Effects of 2′- O -Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials Nucleic Acid Therapeutics ·Stanley T. Crooke, Brenda F. Baker, Joseph L. Witztum, T. Jesse Kwoh, Nguyen C. Pham, Nelson R. Salgado, Bradley McEvoy, Wei Cheng, Steven G. Hughes, Sanjay Bhanot, Richard S. Geary	2017	100
9	First proof of pharmacology in humans of a novel glucagon receptor antisense drug The Journal of Clinical Pharmacology ·Marloes G. J. van Dongen, Bart F. Geerts, Erin Morgan, Teresa Brandt, Marieke L. de Kam, Johannes A. Romijn, Adam F. Cohen, Sanjay Bhanot, Jacobus Burggraaf	2014	37
10	A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis Journal of Biological Chemistry ·Romana Stark, Fitsum Guebre‐Egziabher, Xiaojian Zhao, S. dos S. Quintino, Jianying Dong, Tiago C. Alves, R. A. Manzoni, Rebecca L. Pongratz, Sanjay Bhanot, Michael Roden, Gary W. Cline, Gerald I. Shulman, Richard G. Kibbey	2014	84
11	cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose Homeostasis Journal of Biological Chemistry ·Derek M. Erion, Maya E. Kotas, 清雄半田, Shin Yonemitsu, Jennifer J. Hsiao, Yoshio Nagai, Takanori Iwasaki, Susan F. Murray, Sanjay Bhanot, Gary W. Cline, Varman T. Samuel, Gerald I. Shulman, Matthew P. Gillum	2013	18
12	Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice PLoS ONE ·Xing Yu, Lynnetta M. Watts, Vara Prasad Manchem, Kaushik Chakravarty, Brett P. Monia, Michael L. McCaleb, Sanjay Bhanot	2013	25
13	Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease Journal of Clinical Investigation ·Varman T. Samuel, Zhenxiang Liu, Amy Wang, Sara A. Beddow, John G. Geisler, Mario Kahn, Xianman Zhang, Brett P. Monia, Sanjay Bhanot, Gerald I. Shulman	2007	393
14	Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology ·Kanji Yamaguchi, Liu Yang, Shannon J. McCall, Jiawen Huang, Xing Yu, Sanjay Pandey, Sanjay Bhanot, Brett P. Monia, Yin-xiong Li, Anna Mae Diehl Hit paper breakdown →	2007	805
15	Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance Journal of Biological Chemistry ·Cheol Soo Choi, David B. Savage, Ameya Kulkarni, Xing Yu, Zhenxiang Liu, Katsutaro Morino, Sheene Kim, Alberto Distefano, Varman T. Samuel, Susanne Neschen, Dongyan Zhang, Amy Wang, Xian‐Man Zhang, Mario Kahn, Gary W. Cline, Sanjay K. Pandey, John G. Geisler, Sanjay Bhanot, Brett P. Monia, Gerald I. Shulman	2007	312
16	Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice Journal of Clinical Investigation ·Christoph Buettner, Rima Patel, Evan D. Muse, Sanjay Bhanot, Brett P. Monia, Len Isaias Vallecillo Amador, Silvana Obici, Luciano Rossetti	2005	43
17	Role of resistin in diet-induced hepatic insulin resistance Journal of Clinical Investigation ·Evan D. Muse, Silvana Obici, Sanjay Bhanot, Brett P. Monia, Robert A. McKay, Michael W. Rajala, Philipp E. Scherer, Luciano Rossetti	2004	280
18	Role of resistin in diet-induced hepatic insulin resistance Journal of Clinical Investigation ·Evan D. Muse, Silvana Obici, Sanjay Bhanot, Brett P. Monia, Robert A. McKay, Michael W. Rajala, Philipp E. Scherer, Luciano Rossetti	2004	273
19	Vascular insulin resistance in fructose-hypertensive rats European Journal of Pharmacology ·Subodh Verma, Sanjay Bhanot, Christian C. Colín‐Santana, John H. McNeill	1997	36
20	A novel adenosine receptor subtype from the shark rectal gland activates CFTR chloride channels in Xenopus laevis oocytes Journal of the American Society of Nephrology ·Sanjay Bhanot, R. Biffi, Stephen G. Aller, J. N. Forrest	1996	2

About Sanjay Bhanot

Sanjay Bhanot is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism, Physiology, Molecular Biology and Geriatrics and Gerontology, having authored 109 papers that have together received 11.1k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (23 papers), Adipose Tissue and Metabolism (20 papers), Liver Disease Diagnosis and Treatment (19 papers), Diet, Metabolism, and Disease (19 papers), Pancreatic function and diabetes (18 papers), Lipid metabolism and biosynthesis (11 papers), Vanadium and Halogenation Chemistry (9 papers) and Diet and metabolism studies (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.7k citations), Biochemistry (1.0k citations), Cancer Research (1.9k citations), Physiology (2.7k citations) and Epidemiology (3.5k citations). Sanjay Bhanot has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Brett P. Monia, Robert A. McKay, John H. McNeill, Gerald I. Shulman, Varman T. Samuel, Xing Yu, Sanjay K. Pandey, Lynnetta M. Watts, Subodh Verma and Sheri Booten. Their work appears in journals such as Diabetes, Nucleic Acid Therapeutics, Journal of Clinical Investigation, Journal of Biological Chemistry and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact